Back to search

Article

Directed evolution of angiotensin-converting enzyme 2 (ACE2) peptidase activity profiles for therapeutic applications

2022-01-03

Abstract excerpt

Angiotensin Converting-Enzyme 2 (ACE2) is currently being investigated for its ability to beneficially modulate the Angiotensin receptor (ATR) therapeutic axis to treat multiple human diseases, but its broad substrate scope and diverse physiological roles limit its potential as a therapeutic agent. In this work we engineer ACE2 variants with enhanced hydrolytic activity and specificity toward Angiotensin-II (Ang-I...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b2776a8c-f1d9-5f8b-afa9-3ca58b2da339
DOI
10.1101/2022.01.03.474817
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Directed evolution of angiotensin-converting enzyme 2 (ACE2) peptidase activity profiles for therapeutic applicationsDOI 10.1101/2022.01.03.474817
Select a neighboring publication to make it the new centre.